These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34494428)

  • 1. Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy.
    Dilger AK; Pabbisetty KB; Corte JR; De Lucca I; Fang T; Yang W; Pinto DJP; Wang Y; Zhu Y; Mathur A; Li J; Hou X; Smith D; Sun D; Zhang H; Krishnananthan S; Wu DR; Myers JE; Sheriff S; Rossi KA; Chacko S; Zheng JJ; Galella MA; Ziemba T; Dierks EA; Bozarth JM; Wu Y; Crain E; Wong PC; Luettgen JM; Wexler RR; Ewing WR
    J Med Chem; 2022 Feb; 65(3):1770-1785. PubMed ID: 34494428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits.
    Wong PC; Crain EJ; Bozarth JM; Wu Y; Dilger AK; Wexler RR; Ewing WR; Gordon D; Luettgen JM
    J Thromb Haemost; 2022 Feb; 20(2):399-408. PubMed ID: 34752670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence Pays Off: Milvexian Emerges from the Industry's Longstanding Search for Orally Bioavailable Factor XIa Inhibitors.
    Goodwin NC
    J Med Chem; 2022 Feb; 65(3):1767-1769. PubMed ID: 34962399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species.
    Yang W; Wang Y; Lai A; Clark CG; Corte JR; Fang T; Gilligan PJ; Jeon Y; Pabbisetty KB; Rampulla RA; Mathur A; Kaspady M; Neithnadka PR; Arumugam A; Raju S; Rossi KA; Myers JE; Sheriff S; Lou Z; Zheng JJ; Chacko SA; Bozarth JM; Wu Y; Crain EJ; Wong PC; Seiffert DA; Luettgen JM; Lam PYS; Wexler RR; Ewing WR
    J Med Chem; 2020 Jul; 63(13):7226-7242. PubMed ID: 32456431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212).
    Pinto DJP; Orwat MJ; Smith LM; Quan ML; Lam PYS; Rossi KA; Apedo A; Bozarth JM; Wu Y; Zheng JJ; Xin B; Toussaint N; Stetsko P; Gudmundsson O; Maxwell B; Crain EJ; Wong PC; Lou Z; Harper TW; Chacko SA; Myers JE; Sheriff S; Zhang H; Hou X; Mathur A; Seiffert DA; Wexler RR; Luettgen JM; Ewing WR
    J Med Chem; 2017 Dec; 60(23):9703-9723. PubMed ID: 29077405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups.
    Corte JR; Pinto DJP; Fang T; Osuna H; Yang W; Wang Y; Lai A; Clark CG; Sun JH; Rampulla R; Mathur A; Kaspady M; Neithnadka PR; Li YC; Rossi KA; Myers JE; Sheriff S; Lou Z; Harper TW; Huang C; Zheng JJ; Bozarth JM; Wu Y; Wong PC; Crain EJ; Seiffert DA; Luettgen JM; Lam PYS; Wexler RR; Ewing WR
    J Med Chem; 2020 Jan; 63(2):784-803. PubMed ID: 31833761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor.
    Perera V; Wang Z; Luettgen J; Li D; DeSouza M; Cerra M; Seiffert D
    Clin Transl Sci; 2022 Feb; 15(2):330-342. PubMed ID: 34558200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa.
    Wong PC; Quan ML; Watson CA; Crain EJ; Harpel MR; Rendina AR; Luettgen JM; Wexler RR; Schumacher WA; Seiffert DA
    J Thromb Thrombolysis; 2015 Nov; 40(4):416-23. PubMed ID: 26249722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally bioavailable amine-linked macrocyclic inhibitors of factor XIa.
    Fang T; Corte JR; Gilligan PJ; Jeon Y; Osuna H; Rossi KA; Myers JE; Sheriff S; Lou Z; Zheng JJ; Harper TW; Bozarth JM; Wu Y; Luettgen JM; Seiffert DA; Wexler RR; Lam PYS
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126949. PubMed ID: 31932224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats.
    Schumacher WA; Seiler SE; Steinbacher TE; Stewart AB; Bostwick JS; Hartl KS; Liu EC; Ogletree ML
    Eur J Pharmacol; 2007 Sep; 570(1-3):167-74. PubMed ID: 17597608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group.
    Corte JR; Fang T; Pinto DJ; Orwat MJ; Rendina AR; Luettgen JM; Rossi KA; Wei A; Ramamurthy V; Myers JE; Sheriff S; Narayanan R; Harper TW; Zheng JJ; Li YX; Seiffert DA; Wexler RR; Quan ML
    Bioorg Med Chem; 2016 May; 24(10):2257-72. PubMed ID: 27073051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-Based Lead Generation of 5-Phenyl-1
    Wei Q; Zheng Z; Zhang S; Zheng X; Meng F; Yuan J; Xu Y; Huang C
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.
    Heitmeier S; Visser M; Tersteegen A; Dietze-Torres J; Glunz J; Gerdes C; Laux V; Stampfuss J; Roehrig S
    J Thromb Haemost; 2022 Jun; 20(6):1400-1411. PubMed ID: 35289054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milvexian for the Prevention of Venous Thromboembolism.
    Weitz JI; Strony J; Ageno W; Gailani D; Hylek EM; Lassen MR; Mahaffey KW; Notani RS; Roberts R; Segers A; Raskob GE;
    N Engl J Med; 2021 Dec; 385(23):2161-2172. PubMed ID: 34780683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits.
    Wong PC; Crain EJ; Watson CA; Schumacher WA
    J Thromb Thrombolysis; 2011 Aug; 32(2):129-37. PubMed ID: 21614454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions.
    Xu G; Liu Z; Wang X; Lu T; DesJarlais RL; Thieu T; Zhang J; Devine ZH; Du F; Li Q; Milligan CM; Shaffer P; Cedervall PE; Spurlino JC; Stratton CF; Pietrak B; Szewczuk LM; Wong V; Steele RA; Bruinzeel W; Chintala M; Silva J; Gaul MD; Macielag MJ; Nargund R
    J Med Chem; 2022 Aug; 65(15):10419-10440. PubMed ID: 35862732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.
    Roehrig S; Ackerstaff J; Jiménez Núñez E; Teller H; Ellerbrock P; Meier K; Heitmeier S; Tersteegen A; Stampfuss J; Lang D; Schlemmer KH; Schaefer M; Gericke KM; Kinzel T; Meibom D; Schmidt M; Gerdes C; Follmann M; Hillisch A
    J Med Chem; 2023 Sep; 66(17):12203-12224. PubMed ID: 37669040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel FXIa inhibitors with 2-phenyl-1H-imidazole-5-carboxamide moiety as P1 fragment.
    Lei Y; Zhang B; Zhang Y; Dai X; Duan Y; Mao Q; Gao J; Yang Y; Bao Z; Fu X; Ping K; Yan C; Mou Y; Wang S
    Eur J Med Chem; 2021 Aug; 220():113437. PubMed ID: 33894565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activity.
    Hangeland JJ; Friends TJ; Rossi KA; Smallheer JM; Wang C; Sun Z; Corte JR; Fang T; Wong PC; Rendina AR; Barbera FA; Bozarth JM; Luettgen JM; Watson CA; Zhang G; Wei A; Ramamurthy V; Morin PE; Bisacchi GS; Subramaniam S; Arunachalam P; Mathur A; Seiffert DA; Wexler RR; Quan ML
    J Med Chem; 2014 Dec; 57(23):9915-32. PubMed ID: 25405503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.